Skip to main content

Wave Life Sciences First Quarter 2026 Financial Results Scheduled for April 28, 2026

CAMBRIDGE, Mass., April 22, 2026 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conference call at 8:30 a.m. ET on Tuesday, April 28, 2026, to review the company’s first quarter 2026 financial results and provide business updates. The webcast and conference call may be accessed by visiting “Investor Events” on the investors section of the Wave Life Sciences website: https://ir.wavelifesciences.com/events-publications/events. Analysts planning to participate during the Q&A portion of the live call can join the conference call at the audio-conferencing link here. Following the live event, an archived version of the webcast will be available on the Wave Life Sciences...

Continue reading

Greif Commits to Science Based Targets Initiative and Releases 17th Annual Sustainability Report

Demonstrating continued climate leadership, innovation, and measurable sustainability progress DELAWARE, Ohio, April 22, 2026 (GLOBE NEWSWIRE) — Greif, Inc. (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, today announced that it has formally committed to the Science Based Targets initiative (SBTi), marking a significant milestone in the company’s long-standing approach to climate action and emissions reduction. The company also released its 17th annual Sustainability Report, highlighting 2025 progress in advancing its responsible business practices and long-term value creation. Advancing Toward Science-Based Net-Zero TargetsThrough its SBTi commitment, Greif will develop science-based near-term and long-term greenhouse gas emissions reduction targets, including Scope 3 value chain emissions reduction...

Continue reading

Hudson Technologies to Host Conference Call to Discuss First Quarter 2026 Results

WOODCLIFF LAKE, N.J., April 22, 2026 (GLOBE NEWSWIRE) — Hudson Technologies, Inc. (NASDAQ: HDSN) will host a conference call and webcast on Wednesday, May 6, 2026 at 5:00 p.m. Eastern Time to discuss the Company’s first quarter 2026 results. Please visit this link at least 5 minutes prior to the scheduled start time in order to register and receive dial-in and webcast details. A replay of the teleconference will be available until June 5, 2026, and may be accessed by dialing (877) 481-4010. International callers may dial (919) 882-2331. Callers should use conference ID: 53874. About Hudson Technologies Hudson Technologies, Inc. is a leading provider of innovative and sustainable refrigerant products and services to the Heating Ventilation Air Conditioning and Refrigeration industry. For nearly three decades, we have demonstrated...

Continue reading

Netcapital Expands Strategy to Build Full-Service Capital Markets Infrastructure for Growth Companies

Boston, MA, April 22, 2026 (GLOBE NEWSWIRE) — Netcapital Inc. (Nasdaq: NCPL, NCPLW) (“Netcapital” or the “Company”), a publicly traded fintech company that gives companies access to capital markets infrastructure without institutional scale fees, today announced its strategic focus on enhancing the Netcapital platform into a more full-service capital formation solution for emerging growth companies. Under the leadership of Chief Executive Officer Todd Violette, Netcapital plans to build on its existing SEC-registered funding portal and FINRA member broker-dealer capabilities by expanding the services and tools that support issuers throughout the capital raising process. The goal is to provide issuers with a more integrated experience that combines regulatory-compliant technology, marketing support, investor analytics, and advisory...

Continue reading

HeartCore Regains Compliance with Nasdaq Minimum Bid Price Requirement

NEW YORK and TOKYO, April 22, 2026 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), an IPO consulting services company based in Tokyo, today announced that on April 20, 2026, it received written notice from the Listing Qualifications Department of the Nasdaq Stock Market indicating that the Company has regained compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market. Accordingly, the Company’s common stock will continue to be listed and traded on the Nasdaq Capital Market. About HeartCore Enterprises, Inc.HeartCore Enterprises, Inc. is headquartered in Tokyo, Japan, and is a leading consulting services company providing U.S. market listing support and related advisory services primarily to Japanese...

Continue reading

Multi Ways Holdings Expands Singapore Operational Footprint by Approximately 149,000 Square Feet to Support Hybrid and EV Construction Equipment Strategy

New Capacity Anchored by Five-Year Lease on Dedicated Warehouse and Yard Facility; Supports Pivot Toward Higher-Demand, Energy-Efficient Equipment Segments SINGAPORE, April 22, 2026 (GLOBE NEWSWIRE) — Multi Ways Holdings Limited (“Multi Ways,” the “Company” or the “Issuer”) (NYSE American: MWG), a leading supplier of a wide range of heavy construction equipment for sales and rental in Singapore and the surrounding region, today announced that it has secured approximately 149,000 square feet of additional industrial capacity in Singapore to accelerate its strategic expansion into hybrid and electric (EV) construction equipment. The expansion comprises approximately 69,460 square feet of newly leased industrial space secured during the first quarter of 2026, together with a separate dedicated warehouse and yard facility of over 80,000...

Continue reading

Standard Lithium Reaches Major Operational Milestones at Arkansas Demonstration Plant

Processed 1 million barrels of brine, pumped in real-time from the Smackover Formation Completed 15,000 cycles of DLE using the same process to be implemented at the South West Arkansas Project 6 years and 340,000 man hours of operation without a safety incidentVANCOUVER, British Columbia, April 22, 2026 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE.A: SLI), a leading near-commercial lithium company, is pleased to announce the achievement of several meaningful operational milestones at its large-scale Demonstration Plant (the “demo plant” or “facility”) in El Dorado, Arkansas. The demo plant contains a fully operational brine-to-lithium carbonate flowsheet, and at its core is a commercial-scale direct lithium extraction (“DLE”) unit supplied by Aquatech. Since its initial commissioning...

Continue reading

CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026

Ongoing Phase 2 study in metastatic colorectal cancer (mCRC) demonstrates early clinical and biomarker activity with leronlimab in combination with TAS-102 and bevacizumab, supporting CCR5 as a therapeutic target VANCOUVER, Washington, April 22, 2026 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications, including metastatic triple-negative breast cancer (“mTNBC”) and colorectal cancer (“mCRC”), today announced that new clinical data from its ongoing Phase 2 study in metastatic colorectal cancer (mCRC) were presented at the AACR Annual Meeting 2026, taking place April 17–22, 2026, at the San Diego Convention...

Continue reading

Spectral AI’s DeepView® System Showcased at 2026 American Burn Association Annual Meeting

DALLAS, April 22, 2026 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today shared a recap from the 2026 Annual Meeting of the American Burn Association, held April 14-17, 2026 in Orlando, Florida. The theme of this year’s conference, Leading Burn Care into Tomorrow, provided a rich and relevant platform for U.S. and UK clinicians to present various aspects of the DeepView System® to more than 2,200 clinicians, researchers, and burn care leaders from across the globe. The DeepView System is an AI-driven, predictive diagnostic device and associated software platform that combines multispectral imaging with a proprietary AI algorithm to assess the healing potential...

Continue reading

Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®

Members of the Society of Interventional Radiology (SIR) and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Represent the Largest Addressable User Market for the LIBERTY System At least Nine Medical Societies Endorse Updated Guidelines to Lower Radiation Exposure and Improve Ergonomic Issues Impacting Health Practitioners HINGHAM, Mass., April 22, 2026 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, today highlighted that the Society of Interventional Radiology (SIR) and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE), recently released updated joint guidelines on occupational protection in interventional radiology. The revised guideline provides important safety guidance to physicians,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.